30Oct
[Video] I Wish I Knew What I Know Now: Conversations with AGG on FDA Issues - Key Due Diligence Issues to Consider When Acquiring or Investing in Life Sciences Companies or Products
AGG is pleased to present the second episode in a podcast series titled, “I Wish I Know What I Know Now: Conversations with AGG on FDA Issues,” covering key due diligence issues to consider when acquiring or investing in life science companies or products. In this episode, AGG partner Alan G. Minsk and Brian A. Teras provides an overview of the diligence process, potential red flags, common mistakes, and other factors to consider during the due diligence process. Each month, we'll release a...
By:
Arnall Golden Gregory LLP
Related
...The coronavirus (provisionally named SARS-CoV-2, with its disease being named COVID-19) has now b...
Read More >
On February 1, 2021, the Federal Trade Commission (FTC) released the revised thresholds for determin...
Read More >
Millennials, can you relate to your older co-workers? Everybody and their dog has workshops these d...
Read More >
The COVID-19 pandemic has caused more than just health concerns for our community—it has also creat...
Read More >
States Impose Sexual Harassment Policy & Training Requirements - In the wake of the #MeToo Movement...
Read More >
Minnesota employers working to comply with the recently enacted Minnesota Wage Theft Law should be a...
Read More >